Stocks in the News This Week: $TBRIF https://
Post# of 62
https://topnewsguide.com/2022/10/28/7-stocks-...sfwj-sirc/
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) developer of AcuVid™ COVID-19 Rapid Antigen Saliva Test, progressive diagnostics, medical device technologies, etc., announces new US billing codes for its Venowave product giving Therma Bright immediate access to reimbursement through Medicare, Medicaid and other Private Insurance Providers in the US.
Therma Bright announced back on September 20 that it had been successful in selling the updated initial order of its Venowave product to customers in the United States. The sales had been completed through DME Authority, which happened to be the exclusive distributor of Therma Bright.